Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States
Xu Gao, Fan Lv, Xinyuan He, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 16-27
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Michael H. Le, Yee Hui Yeo, Biyao Zou, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 841-850
Open Access | Times Cited: 153
Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
Takanori Ito, Mindie H. Nguyen
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 413-428
Open Access | Times Cited: 32
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 13
Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups
Shoufang Song, Chen Guo, Ruiyun Wu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 12
Alcohol-related liver disease: A global perspective
Graciela Castro‐Narro, Luis Antonio Díaz, E. Ortega, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101499-101499
Open Access | Times Cited: 9
Increased gastrointestinal bleeding-related mortality during the COVID-19 pandemic
Xu Gao, Yee Hui Yeo, Fan Lv, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Ursodeoxycholic acid relieves clinical severity of COVID-19 in patients with chronic liver diseases
Tiantian Hu, Jie Tong, Yunhui Yang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Alcohol-Associated Liver Disease Mortality Rates by Race Before and During the COVID-19 Pandemic in the US
Neeti Kulkarni, Divneet K. Wadhwa, Fasiha Kanwal, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 4, pp. e230527-e230527
Open Access | Times Cited: 14
(Mis)understanding alcohol use disorder: Making the case for a public health first approach
James Morris, Cassandra L. Boness, Robyn Burton
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111019-111019
Open Access | Times Cited: 14
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
Hendrik Luxenburger, Robert Thimme
Gut (2023) Vol. 72, Iss. 9, pp. 1783-1794
Open Access | Times Cited: 13
Higher-Than-Expected Burden of Alcohol-Related Liver Diseases During COVID-19 Pandemic in the USA, with a Tapering Trend
Yichen Wang, Yuting Huang, Chenyu Sun, et al.
Journal of General Internal Medicine (2024) Vol. 39, Iss. 12, pp. 2133-2141
Closed Access | Times Cited: 4
Anti-hepatopathy and anti-nephropathy activities of Taraxacum officinale in a rat model of Streptozotocin diabetes-induced hepatorenal toxicity and dyslipidemia via attenuation of oxidative stress, inflammation, apoptosis, electrolyte imbalances, and mitochondrial dysfunction
Sunday Aderemi Adelakun, Aniah Julius Akomaye, O Omotoso, et al.
Aspects of Molecular Medicine (2024) Vol. 3, pp. 100034-100034
Open Access | Times Cited: 4
Non-invasive visualization of liver fibrosis with [68Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation
Yangmeihui Song, Chunxia Qin, Yixiong Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3572-3584
Closed Access | Times Cited: 4
Addressing racial and ethnic disparities in US liver cancer care
Nicole J. Kim, Anne Cravero, Trang VoPham, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 11
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1724-1724
Open Access | Times Cited: 11
The burden of cirrhosis mortality by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities
Hasan Nassereldine, Kelly Compton, Zhuochen Li, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 8, pp. e551-e563
Open Access | Times Cited: 3
COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
Mohammad Tarique Imam, Ziyad S. Almalki, Abdullah R. Alzahrani, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110439-110439
Open Access | Times Cited: 9
Mortality from chronic liver disease: Recent trends and impact of the COVID-19 pandemic
Ugo Fedeli, Claudio Barbiellini Amidei, Veronica Casotto, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4166-4173
Open Access | Times Cited: 9
Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040
Sikai Qiu, Jiangying Cai, Zhangjie Yang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2445525-e2445525
Open Access | Times Cited: 2
Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic
Yee Hui Yeo, Xinyuan He, Fan Lv, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 13
Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China
Weina Zhang, Lanfang Li, Zhen Zhou, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Racial and Ethnic Disparities in Years of Potential Life Loss Among Patients With Cirrhosis During the COVID-19 Pandemic in the United States
Yunyu Zhao, Yee Hui Yeo, Jamil S. Samaan, et al.
The American Journal of Gastroenterology (2023) Vol. 118, Iss. 4, pp. 752-757
Closed Access | Times Cited: 6
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)
James M. Paik, Katherine Eberly, Khaled W. Kabbara, et al.
Annals of Hepatology (2023) Vol. 28, Iss. 4, pp. 101108-101108
Open Access | Times Cited: 6
Understanding the Changing Landscape of Health Disparities in Chronic Liver Diseases and Liver Cancer
Olga M Herren, Arielle S. Gillman, Vanessa Marshall, et al.
Gastro Hep Advances (2022) Vol. 2, Iss. 4, pp. 505-520
Closed Access | Times Cited: 10
Regional variation in characteristics of patients with decompensated cirrhosis admitted to hospitals in the UK
Oliver Tavabie, Kushala Abeysekera, Paul Brennan, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 7, pp. 604-606
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top